Subsidies
Pick a company. You see which programmes comparable companies received over the last five years, how many of them, for what amount, and which the company itself did not receive.
BE 0402.134.977
Novartis Manufacturing
Manufacture of basic pharmaceutical products and pharmaceutical preparations · Antwerp · Large
Comparison group of 303 companies
The group is made of active legal entities with the same NACE division (21, Pharmaceuticals), across Belgium. Every size counts. The period starts in 2022.
The same region held too few comparable companies. The comparison therefore covers the NACE division across Belgium, any size.
- Flemish subsidies 23% of comparable This company: €84,355 awarded, 1 programme
- Federal transfers 0.7% of comparable This company: nothing in this register
- Wallonia-Brussels Federation 0% of comparable This company: nothing in this register
- EU budget 3.3% of comparable This company: nothing in this register
- EU research 4% of comparable This company: nothing in this register
Programmes Novartis Manufacturing did not receive according to the registers
At least 2 comparable companies received these programmes since 2022. The most shared come first. That others received a programme does not say whether this company qualifies or whether the programme is still open. The Flemish register publishes the names of its programmes in Dutch only: they appear here as it publishes them.
- Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille) For example ORFIT INDUSTRIES, DEBA PHARMA, BIVIT14% 41 of 303 companies median €1,500 awarded
-
5.9% 18 of 303 companies median €9,500 awarded
- Vlaamse ondersteuningspremie (VOP) voor werkgevers (uitdovend stelsel) For example Janssen Pharmaceutica, Organon Heist, PFIZER MANUFACTURING BELGIUM4.6% 14 of 303 companies median €32,465 awarded
- Horizon Europe For example Janssen Pharmaceutica, Quantoom Biosciences, Inteliphage4% 12 of 303 companies median €336,435 EU contribution
- Onderzoeksproject For example Janssen Pharmaceutica, Obulytix, Flindr Labs3% 9 of 303 companies median €497,743 awarded
-
2.6% 8 of 303 companies median €1.1m attributed share
- Ontwikkelingsproject For example GENZYME FLANDERS, Janssen Pharmaceutica, SIMABS2.3% 7 of 303 companies median €459,257 awarded
- Baekeland-mandaat For example Janssen Pharmaceutica, Perseus Biomics, Obulytix2% 6 of 303 companies median €330,631 awarded
-
1.7% 5 of 303 companies median €50,000 awarded
-
1.7% 5 of 303 companies median €22,559 awarded
- Werkbaarheidscheque (discontinued) For example LABORATORIA QUALIPHAR, -HEEL BELGIUM, LABORATORIA WOLFS1.7% 5 of 303 companies median €6,000 awarded
- Strategische transformatiesteun For example GENZYME FLANDERS, Janssen Pharmaceutica, AJINOMOTO OMNICHEM1.3% 4 of 303 companies median €1.0m awarded
Show 8 more
-
1.3% 4 of 303 companies median €442,093 awarded
- Kmo-groeisubsidie: steun voor groeitrajecten bij kmo's (discontinued) For example HEW PHARMA, IDEVAX, INTIBIO1.3% 4 of 303 companies median €50,000 awarded
- Innovatiemandaat For example Janssen Pharmaceutica, Ziphius, SIMABS1% 3 of 303 companies median €241,807 awarded
- Innovatieve starterssteun For example Evarmed, FiriX Therapeutics, RheADC1% 3 of 303 companies median €50,000 awarded
- Decentralised Agencies, Joint Undertakings, EU institutions For example Obulytix, Janssen Pharmaceutica0.7% 2 of 303 companies median €1.5m attributed share
-
0.7% 2 of 303 companies median €323,391 awarded
- Premie kwalificerend werkplekleren For example AJINOMOTO OMNICHEM, LAMBO Laboratoria - LAMBO Laboratoires0.7% 2 of 303 companies median €1,000 awarded
- Stagebonus (discontinued) For example GENZYME FLANDERS, BIVIT0.7% 2 of 303 companies median €1,000 awarded
Programmes Novartis Manufacturing also received
1- Vlaams opleidingsverlof (VOV) For example PFIZER MANUFACTURING BELGIUM, AJINOMOTO OMNICHEM, Janssen Pharmaceutica8.6% 26 of 303 companies median €7,542 awarded